Table 2. Treatment groups and the formulation administered to each one.
Administration route: | Oral | Oral | Oral | Oral | Oral | Intramuscular |
Groups (n = 5) | I | II | III | IV | V | VI |
PBS | X | X | ||||
Chitosan NPs * | X | |||||
SmRho (solution) | 50 µg | |||||
SmRho loaded alginate coated chitosan NPs | 50 µg | 50 µg | ||||
SmRho-CpGODN loaded alginate coated chitosan NPs | 50 µg+10 µg |
NPs: Nanoparticles.